Wingkie Wong

Wingkie Wong, currently employed at Zymeworks Inc., has a strong background in developing and conducting in vitro functional assays to assess novel antibody-based therapeutics for cancer and infectious diseases. They have extensive experience in optimizing mammalian cell culture, ELISA assays, and implementing biopanning strategies against bacterial and viral targets. Wingkie also has experience in high-throughput cell-based screening assays and has contributed to characterizing anti-inflammatory signaling pathways during their time at The University of British Columbia. Their educational background includes a Bachelor of Science in Biochemistry from The University of British Columbia.